evidencegaps
Primary study · included by 1 review

Efficacy and safety of pembrolizumab with preoperative neoadjuvant chemotherapy in patients with resectable locally advanced head and neck squamous cell carcinomas.

Wang 2023 · Wang Kai, Gui Lin, Lu Haizhen, et al. · Frontiers in immunology · 2023

Included by

The Efficacy and Safety of Neoadjuvant Immunotherapy in Pan-Squamous Cell Carcinomas: A Meta-Analysis of Esophageal, Head and Neck, Cervical, Lung, Cutaneous, and Oral Squamous Cell Carcinomas.
Non-Cochrane · intervention · 2026 · cited as Wang 2023 · Supplementary Table S1; reference list

The review does not say which of its outcomes this study informs.

1 including review in total.